FCA
BLFS icon

FinTrust Capital Advisors’s BioLife Solutions BLFS Stock Holding History

FinTrust Capital Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-84
Closed -$1.53K – 1242
2023
Q2 		$1.53K Hold
84
– – ﹤0.01% 1057
2023
Q1 		$1.53K Hold
84
– – ﹤0.01% 1049
2022
Q4 		$1.53K Sell
84
-211
-72% -$4.36K ﹤0.01% 1046
2022
Q3 		$6K Buy
295
+31
+12% +$663 ﹤0.01% 980
2022
Q2 		$5K Hold
264
– – ﹤0.01% 1021
2022
Q1 		$6K Buy
264
+238
+915% +$6.27K ﹤0.01% 1031
2021
Q4 		$1K Buy
+26
New +$1.12K ﹤0.01% 1134

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FinTrust Capital Advisors's BLFS Position: Q3 2023 in Review

FinTrust Capital Advisors sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 84 shares — an estimated $1.53K sold.

FinTrust Capital Advisors first reported a position in BLFS in Q4 2021 and held it in 7 quarters. The position peaked at $6K in Q3 2022. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • FinTrust Capital Advisors reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • FinTrust Capital Advisors sold 84 BioLife Solutions shares in Q3 2023, an estimated $1.53K.
  • FinTrust Capital Advisors first reported a position in BioLife Solutions in Q4 2021 and held it in 7 quarters.
  • FinTrust Capital Advisors's BioLife Solutions position peaked at $6K in Q3 2022.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on FinTrust Capital Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.